WeightCare Review

WeightCare review: a pharmacy-quality pitch for compounded GLP-1s

WeightCare is a Fort Lauderdale-based telehealth program built around one core argument: that the pharmacy mixing your medication matters as much as the medication itself. It dispenses compounded semaglutide and tirzepatide through FDA-registered, PCAB-accredited pharmacy partners and publishes quality-testing details for potency and sterility under USP 797 standards. If you've been burned by — or are nervous about — fly-by-night compounding, that emphasis is the reason to look here. If you want brand-name Wegovy or Zepbound, this isn't the place: WeightCare is compounded-only.

Who WeightCare is really for

This is a solid fit for the cost-conscious patient who still wants to know where their medication comes from. WeightCare leans hard on its pharmacy credentials and a real physical address (2950 Griffin Rd, Fort Lauderdale), and it claims more than 85,000 members since 2022 — an established base rather than a brand-new startup. The trade-off is that it sells only compounded versions of both drugs, so anyone who needs FDA-approved brand product, or who wants insurance billing, should look elsewhere.

How the pricing actually works — and why it's not one simple number

WeightCare's pricing is genuinely mixed, so it's worth understanding the structure before you pick a plan. Semaglutide and tirzepatide each come in a month-to-month option and longer 3- and 6-month commitments, and the longer you prepay, the lower your effective monthly rate drops — down to $215 a month on the longest semaglutide plan. For context, that undercuts the category median of roughly $170 a month.

The two drugs price differently, though:

• Semaglutide, monthly: a flat rate that does not climb as your dose goes up — the same price even at the highest dose, which is unusual and patient-friendly. The discounted 3-month plan is limited to new patients on starter doses.
• Tirzepatide, monthly: a single rate that covers every dose from 2.5 mg up to 15 mg per week.
• Tirzepatide, multi-month: here the price is tiered by dose — the cheaper 3- and 6-month plans cap at 7.5 mg/week, and you pay a higher rate for a separate high-dose plan that goes up to 15 mg/week.

The practical takeaway: semaglutide is the simpler, more predictable choice on price, while tirzepatide rewards you for prepaying only if you stay at a standard dose. If you expect to titrate up to 15 mg, budget for the high-dose plan rather than assuming the headline 6-month rate applies to you.

What's in the box, and what costs extra

Every plan bundles the medication, a telehealth visit (WeightCare advertises same-day availability), shipping, ongoing physician support with monthly check-ins, and access to its app. That's a clean, all-in package for the core service.

One honest caveat: despite marketing that pairs 'Doctor + Meds + Health Coaches,' the coaching, dietitian, and fitness-trainer support is sold as separate add-on products in WeightCare's store — monthly personal coaching and single- or multi-session packages — not clearly baked into the program price. If hands-on coaching is the reason you're choosing WeightCare, confirm exactly what's included before you pay, because the human-support piece may be an upcharge.

The medications and how they're dispensed

Both semaglutide and tirzepatide are compounded — custom-mixed by a pharmacy rather than manufactured as FDA-approved brand product. WeightCare's differentiator is the caliber of those pharmacies: PCAB accreditation is one of the strongest third-party quality signals in compounding, and the company points to documented potency and sterility testing under USP 797. There's also a micro-dose semaglutide program for patients who do better easing in slowly or staying at a low maintenance dose.

Trust and safety: strong on pharmacy, thinner on disclosure

The verification picture is reassuring in the place that matters most for compounded drugs — the pharmacy — but incomplete elsewhere. On the plus side: no FDA warning letters are on file, the PCAB accreditation and USP 797 testing are real quality signals, and there's a verifiable physical address. On the other side, WeightCare does not display LegitScript certification on its own site, and it doesn't publicly list which states it serves, so you'll want to confirm availability in your state before signing up. None of this is a red flag, but it's less transparency than the best-documented providers offer. See our scoring methodology for how we weigh these signals.

Where WeightCare falls short

• Compounded-only — no brand-name Wegovy, Ozempic, or Zepbound, and no insurance pathway.
• No LegitScript certification shown on the site.
• State availability isn't published, so eligibility takes a phone call or email to confirm.
• Coaching is marketed prominently but appears to be a paid add-on rather than included.
• Tirzepatide's best multi-month rates only apply at standard doses (≤7.5 mg/week).

Bottom line

WeightCare earns its keep on pharmacy quality. If your top priority is knowing your compounded GLP-1 comes from a PCAB-accredited, USP 797-tested pharmacy at a competitive price — and the dose-flat monthly semaglutide plan is especially appealing here — it's a credible, established option with a real track record. Just go in clear-eyed: it's compounded-only, the state list and LegitScript status aren't posted, coaching may cost extra, and tirzepatide's cheapest plans assume a standard dose. Confirm those specifics for your situation, and WeightCare is a reasonable pick for the value-minded patient who still wants quality assurance behind the syringe.

Worth pricing against Enhance MD ($212/month) and bmiMD ($99/month) before you commit — both sit close to WeightCare on cost and formulation.